BioCryst Pharmaceuticals, Inc. (BCRX) Financials
BCRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 465.1 million | 1.0 billion |
| Dec. 31, 2025 | 514.2 million | 633.3 million |
| Sept. 30, 2025 | 446.4 million | 834.3 million |
| June 30, 2025 | 457.2 million | 878.8 million |
BCRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -62.5 million | 16.0 million |
| Dec. 31, 2025 | 275.2 million | 72.6 million |
| Sept. 30, 2025 | 39.8 million | 18.6 million |
| June 30, 2025 | 41.1 million | 21.3 million |
BCRX Net Income
No data available :(
BCRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 239.3 million | 802.4 million | 12.3 million |
| Dec. 31, 2025 | 274.7 million | 427.2 million | 10.0 million |
| Sept. 30, 2025 | 212.9 million | 633.5 million | 12.0 million |
| June 30, 2025 | 260.0 million | 690.6 million | 12.5 million |
BCRX Shares Outstanding
BCRX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 403000 | 60.3 million | 94.6 million | - |
| Dec. 31, 2025 | 802000 | 41.2 million | 95.8 million | - |
| Sept. 30, 2025 | 1.3 million | 44.3 million | 83.0 million | - |
| June 30, 2025 | 179000 | 43.4 million | 87.4 million | - |
BCRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 156.4 million | 703.1 million |
| Dec. 31, 2025 | 406.6 million | 9.9 million |
| Sept. 30, 2025 | 159.4 million | 2.5 million |
| June 30, 2025 | 163.4 million | 2.8 million |
BCRX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BCRX
Price: $9.34
52 week price:
Earnings Per Share: -1.77 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -12.8 millionMarket Capitalization: 2.1 billion